We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
LEF1
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • LEF1
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

LEF1
Synonyms TCF10, TCF1ALPHA, TCF7L3
Gene descriptioni

Full gene name according to HGNC.

Lymphoid enhancer binding factor 1
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Cancer-related genes
Plasma proteins
Transcription factors
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 4
Cytoband q25
Chromosome location (bp) 108047545 - 108168956
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

6
Ensembl ENSG00000138795 (version 103.38)
Entrez gene 51176
HGNC HGNC:6551
UniProt Q9UJU2 (UniProt - Evidence at protein level)
neXtProt NX_Q9UJU2
Antibodypedia LEF1 antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 3      # Population variants: 195

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
LEF1-201
LEF1-202
LEF1-203
LEF1-216
LEF1-218
LEF1-221


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
LEF1-201
ENSP00000265165
ENST00000265165
Q9UJU2 [Direct mapping]
Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription regulatory region sequence-specific DNA binding]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001569 [branching involved in blood vessel morphogenesis]
GO:0001649 [osteoblast differentiation]
GO:0001756 [somitogenesis]
GO:0001837 [epithelial to mesenchymal transition]
GO:0001944 [vasculature development]
GO:0002040 [sprouting angiogenesis]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of transcription, DNA-templated]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0007223 [Wnt signaling pathway, calcium modulating pathway]
GO:0008013 [beta-catenin binding]
GO:0008134 [transcription factor binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0021542 [dentate gyrus development]
GO:0021766 [hippocampus development]
GO:0021861 [forebrain radial glial cell differentiation]
GO:0021873 [forebrain neuroblast division]
GO:0021943 [formation of radial glial scaffolds]
GO:0022407 [regulation of cell-cell adhesion]
GO:0030111 [regulation of Wnt signaling pathway]
GO:0030223 [neutrophil differentiation]
GO:0030284 [estrogen receptor activity]
GO:0030326 [embryonic limb morphogenesis]
GO:0030331 [estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030509 [BMP signaling pathway]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0030879 [mammary gland development]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0033153 [T cell receptor V(D)J recombination]
GO:0042100 [B cell proliferation]
GO:0042393 [histone binding]
GO:0042475 [odontogenesis of dentin-containing tooth]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043401 [steroid hormone mediated signaling pathway]
GO:0043565 [sequence-specific DNA binding]
GO:0043586 [tongue development]
GO:0043923 [positive regulation by host of viral transcription]
GO:0043966 [histone H3 acetylation]
GO:0043967 [histone H4 acetylation]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045843 [negative regulation of striated muscle tissue development]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046632 [alpha-beta T cell differentiation]
GO:0048341 [paraxial mesoderm formation]
GO:0048468 [cell development]
GO:0050909 [sensory perception of taste]
GO:0060033 [anatomical structure regression]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060325 [face morphogenesis]
GO:0060326 [cell chemotaxis]
GO:0060561 [apoptotic process involved in morphogenesis]
GO:0060710 [chorio-allantoic fusion]
GO:0061153 [trachea gland development]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0071899 [negative regulation of estrogen receptor binding]
GO:1902262 [apoptotic process involved in blood vessel morphogenesis]
GO:1904837 [beta-catenin-TCF complex assembly]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
399 aa
44.2 kDa
No 0
LEF1-202
ENSP00000369284
ENST00000379951
Q9UJU2 [Direct mapping]
Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001649 [osteoblast differentiation]
GO:0001837 [epithelial to mesenchymal transition]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0007223 [Wnt signaling pathway, calcium modulating pathway]
GO:0008013 [beta-catenin binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0030223 [neutrophil differentiation]
GO:0030284 [estrogen receptor activity]
GO:0030331 [estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0042393 [histone binding]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043401 [steroid hormone mediated signaling pathway]
GO:0043565 [sequence-specific DNA binding]
GO:0043923 [positive regulation by host of viral transcription]
GO:0043966 [histone H3 acetylation]
GO:0043967 [histone H4 acetylation]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060326 [cell chemotaxis]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0071899 [negative regulation of estrogen receptor binding]
GO:1904837 [beta-catenin-TCF complex assembly]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
386 aa
42.7 kDa
No 0
LEF1-203
ENSP00000406176
ENST00000438313
Q9UJU2 [Direct mapping]
Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001649 [osteoblast differentiation]
GO:0001837 [epithelial to mesenchymal transition]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0007223 [Wnt signaling pathway, calcium modulating pathway]
GO:0008013 [beta-catenin binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0022408 [negative regulation of cell-cell adhesion]
GO:0022409 [positive regulation of cell-cell adhesion]
GO:0030223 [neutrophil differentiation]
GO:0030284 [estrogen receptor activity]
GO:0030331 [estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0042393 [histone binding]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043401 [steroid hormone mediated signaling pathway]
GO:0043565 [sequence-specific DNA binding]
GO:0043923 [positive regulation by host of viral transcription]
GO:0043966 [histone H3 acetylation]
GO:0043967 [histone H4 acetylation]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060326 [cell chemotaxis]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0071899 [negative regulation of estrogen receptor binding]
GO:0090068 [positive regulation of cell cycle process]
GO:1904837 [beta-catenin-TCF complex assembly]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
371 aa
41.2 kDa
No 0
LEF1-216
ENSP00000422840
ENST00000510624
Q9UJU2 [Direct mapping]
Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001649 [osteoblast differentiation]
GO:0001837 [epithelial to mesenchymal transition]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0007223 [Wnt signaling pathway, calcium modulating pathway]
GO:0008013 [beta-catenin binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0030223 [neutrophil differentiation]
GO:0030284 [estrogen receptor activity]
GO:0030331 [estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0042393 [histone binding]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043401 [steroid hormone mediated signaling pathway]
GO:0043565 [sequence-specific DNA binding]
GO:0043923 [positive regulation by host of viral transcription]
GO:0043966 [histone H3 acetylation]
GO:0043967 [histone H4 acetylation]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060326 [cell chemotaxis]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0071899 [negative regulation of estrogen receptor binding]
GO:1904837 [beta-catenin-TCF complex assembly]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
303 aa
34.1 kDa
No 0
LEF1-218
ENSP00000427365
ENST00000512172
D6RIV1 [Direct mapping]
Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0016055 [Wnt signaling pathway]
Show all
145 aa
15.8 kDa
No 0
LEF1-221
ENSP00000422801
ENST00000515500
D6RAB1 [Direct mapping]
Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0016055 [Wnt signaling pathway]
Show all
173 aa
18.8 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.